March 2, 2022
MiGenTra Announces Formation of International Advisory Board
MiGenTra, headquartered in Berlin, Germany and MiGenTra Egypt, located with its ‘Facility of the Future’ in Cairo, Egypt, have announced…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Middle East and North Africa
March 1, 2022
Kingdom of Bahrain OKs Valneva’s Inactivated COVID-19 Vaccine
National Health Regulatory Authority (NHRA) of the Kingdom of Bahrain has granted emergency use authorization for Valneva’s inactivated, adjuvanted COVID-19…
February 9, 2022
Novel Concepts Medical announces breakthrough in COVID-19 research
The startup company Novel Concepts Medical has announced major breakthrough in its research of COVID-19. Its novel plant-based treatment has…
April 15, 2021
Genentech’s Evrysdi Continues to Improve Motor Function and Survival in Babies With Type 1 Spinal Muscular Atrophy (SMA)
– More than twice as many babies (61% vs. 29%) were able to sit without support for at least five…
June 15, 2020
Hikma, Sun Pharma in licensing agreement for Ilumya for the MENA region
Hikma Pharmaceuticals and a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd. (Sun Pharma), the world’s fourth largest specialty generic pharmaceutical company, announced today that they have entered into an exclusive licensing and distribution agreement for Ilumya, an innovative biologic product, for the Middle East and North Africa (MENA) region.
June 12, 2020
CPhI Middle East & Africa to debut in Saudi Arabia in 2021
CPhI Middle East & Africa has been cancelled due to the COVID-19 pandemic, the 2020 edition of the show, scheduled to take place in September in Abu Dhabi. A new earlier date and location for the event has been disclosed, with the show debuting in Riyadh, Saudi Arabia on March 2021.
May 15, 2020
Can-Fite working on a strong candidate for the potential treatment of COVID-19
CanFite is working on Piclidenoson’s anti-viral, anti-inflammatory, anti-rheumatic properties and excellent safety profile make it a strong candidate for the…
May 11, 2020
Nucleix expands footprint for U.S. Growth of Liquid Biopsy Development
Nucleix has appointed new CEO, CFO, General Manager and board member, as it opens San Diego office.
May 7, 2020
Teva reports first quarter 2020 revenues of $4.4 billion
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended March 31, 2020, including revenues…
April 22, 2020
– Israel’s MigVax nets $12 million in investment round
MigVax is getting an investment of $12 million to accelerate path to clinical trials and bring Israel’s human coronavirus vaccine to market, as it pioneers the effort to develop Israel’s human vaccine against COVID-19.